HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

recombinant FVIIa (rFVIIa)

developed for treatment of bleeding episodes in persons with hemophilia complicated by inhibitor antibodies
Also Known As:
rFVIIa; Novo Seven; coagulation factor viia recombinant human; eptacog alfa; eptacog beta; novoseven; recombinant coagulation factor viia; recombinant factor VIIa
Networked: 1937 relevant articles (318 outcomes, 360 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Hedner, Ulla: 23 articles (06/2015 - 01/2000)
2. Holcomb, John B: 22 articles (07/2011 - 08/2002)
3. Hedner, U: 21 articles (09/2011 - 01/2000)
4. Mayer, Stephan A: 17 articles (01/2022 - 10/2002)
5. Franchini, Massimo: 17 articles (09/2018 - 03/2005)
6. Ezban, M: 15 articles (11/2017 - 04/2000)
7. Ingerslev, J: 15 articles (09/2016 - 01/2000)
8. Kenet, G: 14 articles (05/2018 - 04/2000)
9. Martinowitz, U: 13 articles (09/2013 - 04/2000)
10. Skolnick, Brett E: 13 articles (10/2011 - 01/2005)

Related Diseases

1. Hemorrhage
2. Hemophilia A (Haemophilia)
3. Wounds and Injuries (Trauma)
4. Thrombocytopenia (Thrombopenia)
5. Thrombosis (Thrombus)

Related Drugs and Biologics

1. recombinant FVIIa (rFVIIa)
2. Factor VIIa (Activated Factor VII)
3. Hemostatics (Antihemorrhagics)
4. Factor VIII (Coagulation Factor VIII)
5. Antibodies
6. Prothrombin (Factor II)
7. anti-inhibitor coagulant complex
8. Factor VII (Proconvertin)
9. Thrombin
10. prothrombin complex concentrates (PPSB)

Related Therapies and Procedures

1. Therapeutics
2. Operative Surgical Procedures
3. Platelet Transfusion (Blood Platelet Transfusions)
4. Orthopedic Procedures
5. Injections